Cargando…

The Prevalence and Incidence of Atrial Fibrillation in Patients with Acute Pulmonary Embolism

BACKGROUND: Symptomatic pulmonary embolism (PE) is a major cause of cardiovascular death and morbidity. Estimated prevalence and incidence of atrial fibrillation (AF) in developed countries are between 388–661 per 100,000, and 90–123 per 100,000 person-years respectively. However, the prevalence and...

Descripción completa

Detalles Bibliográficos
Autores principales: Ng, Austin Chin Chwan, Adikari, Dona, Yuan, David, Lau, Jerrett K., Yong, Andy Sze Chiang, Chow, Vincent, Kritharides, Leonard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4773188/
https://www.ncbi.nlm.nih.gov/pubmed/26930405
http://dx.doi.org/10.1371/journal.pone.0150448
_version_ 1782418692548591616
author Ng, Austin Chin Chwan
Adikari, Dona
Yuan, David
Lau, Jerrett K.
Yong, Andy Sze Chiang
Chow, Vincent
Kritharides, Leonard
author_facet Ng, Austin Chin Chwan
Adikari, Dona
Yuan, David
Lau, Jerrett K.
Yong, Andy Sze Chiang
Chow, Vincent
Kritharides, Leonard
author_sort Ng, Austin Chin Chwan
collection PubMed
description BACKGROUND: Symptomatic pulmonary embolism (PE) is a major cause of cardiovascular death and morbidity. Estimated prevalence and incidence of atrial fibrillation (AF) in developed countries are between 388–661 per 100,000, and 90–123 per 100,000 person-years respectively. However, the prevalence and incidence of AF in patients presenting with an acute PE and its predictors are not clear. METHODS: Individual patient clinical details were retrieved from a database containing all confirmed acute PE presentations to a tertiary institution from 2001–2012. Prevalence and incidence of AF was tracked from a population registry by systematically searching for AF during any hospital admission (2000–2013) based on International Classification of Disease (ICD-10) code. RESULTS: Of the 1,142 patients included in this study, 935 (81.9%) had no AF during index PE admission whilst 207 patients had documented baseline AF (prevalence rate 18,126 per 100,000; age-adjusted 4,672 per 100,000). Of the 935 patients without AF, 126 developed AF post-PE (incidence rate 2,778 per 100,000 person-years; age-adjusted 984 per 100,000 person-years). Mean time from PE to subsequent AF was 3.4 ± 2.9 years. Total mortality (mean follow-up 5.0 ± 3.7 years) was 42% (n = 478): 35% (n = 283), 59% (n = 119) and 60% (n = 76) in the no AF, baseline AF and subsequent AF cohorts respectively. Independent predictors for subsequent AF after acute PE include age (hazard ratio [HR] 1.06, 95% confidence interval [CI] 1.04–1.08, p<0.001), history of congestive cardiac failure (HR 1.88, 95% CI 1.12–3.16, p = 0.02), diabetes (HR 1.72, 95% CI 1.07–2.77, p = 0.02), obstructive sleep apnea (HR 4.83, 1.48–15.8, p = 0.009) and day-1 serum sodium level during index PE admission (HR 0.94, 95% CI 0.90–0.98, p = 0.002). CONCLUSIONS: Patients presenting with acute PE have a markedly increased age-adjusted prevalence and subsequent incidence of AF. Screening for AF may be of importance post-PE.
format Online
Article
Text
id pubmed-4773188
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-47731882016-03-07 The Prevalence and Incidence of Atrial Fibrillation in Patients with Acute Pulmonary Embolism Ng, Austin Chin Chwan Adikari, Dona Yuan, David Lau, Jerrett K. Yong, Andy Sze Chiang Chow, Vincent Kritharides, Leonard PLoS One Research Article BACKGROUND: Symptomatic pulmonary embolism (PE) is a major cause of cardiovascular death and morbidity. Estimated prevalence and incidence of atrial fibrillation (AF) in developed countries are between 388–661 per 100,000, and 90–123 per 100,000 person-years respectively. However, the prevalence and incidence of AF in patients presenting with an acute PE and its predictors are not clear. METHODS: Individual patient clinical details were retrieved from a database containing all confirmed acute PE presentations to a tertiary institution from 2001–2012. Prevalence and incidence of AF was tracked from a population registry by systematically searching for AF during any hospital admission (2000–2013) based on International Classification of Disease (ICD-10) code. RESULTS: Of the 1,142 patients included in this study, 935 (81.9%) had no AF during index PE admission whilst 207 patients had documented baseline AF (prevalence rate 18,126 per 100,000; age-adjusted 4,672 per 100,000). Of the 935 patients without AF, 126 developed AF post-PE (incidence rate 2,778 per 100,000 person-years; age-adjusted 984 per 100,000 person-years). Mean time from PE to subsequent AF was 3.4 ± 2.9 years. Total mortality (mean follow-up 5.0 ± 3.7 years) was 42% (n = 478): 35% (n = 283), 59% (n = 119) and 60% (n = 76) in the no AF, baseline AF and subsequent AF cohorts respectively. Independent predictors for subsequent AF after acute PE include age (hazard ratio [HR] 1.06, 95% confidence interval [CI] 1.04–1.08, p<0.001), history of congestive cardiac failure (HR 1.88, 95% CI 1.12–3.16, p = 0.02), diabetes (HR 1.72, 95% CI 1.07–2.77, p = 0.02), obstructive sleep apnea (HR 4.83, 1.48–15.8, p = 0.009) and day-1 serum sodium level during index PE admission (HR 0.94, 95% CI 0.90–0.98, p = 0.002). CONCLUSIONS: Patients presenting with acute PE have a markedly increased age-adjusted prevalence and subsequent incidence of AF. Screening for AF may be of importance post-PE. Public Library of Science 2016-03-01 /pmc/articles/PMC4773188/ /pubmed/26930405 http://dx.doi.org/10.1371/journal.pone.0150448 Text en © 2016 Ng et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Ng, Austin Chin Chwan
Adikari, Dona
Yuan, David
Lau, Jerrett K.
Yong, Andy Sze Chiang
Chow, Vincent
Kritharides, Leonard
The Prevalence and Incidence of Atrial Fibrillation in Patients with Acute Pulmonary Embolism
title The Prevalence and Incidence of Atrial Fibrillation in Patients with Acute Pulmonary Embolism
title_full The Prevalence and Incidence of Atrial Fibrillation in Patients with Acute Pulmonary Embolism
title_fullStr The Prevalence and Incidence of Atrial Fibrillation in Patients with Acute Pulmonary Embolism
title_full_unstemmed The Prevalence and Incidence of Atrial Fibrillation in Patients with Acute Pulmonary Embolism
title_short The Prevalence and Incidence of Atrial Fibrillation in Patients with Acute Pulmonary Embolism
title_sort prevalence and incidence of atrial fibrillation in patients with acute pulmonary embolism
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4773188/
https://www.ncbi.nlm.nih.gov/pubmed/26930405
http://dx.doi.org/10.1371/journal.pone.0150448
work_keys_str_mv AT ngaustinchinchwan theprevalenceandincidenceofatrialfibrillationinpatientswithacutepulmonaryembolism
AT adikaridona theprevalenceandincidenceofatrialfibrillationinpatientswithacutepulmonaryembolism
AT yuandavid theprevalenceandincidenceofatrialfibrillationinpatientswithacutepulmonaryembolism
AT laujerrettk theprevalenceandincidenceofatrialfibrillationinpatientswithacutepulmonaryembolism
AT yongandyszechiang theprevalenceandincidenceofatrialfibrillationinpatientswithacutepulmonaryembolism
AT chowvincent theprevalenceandincidenceofatrialfibrillationinpatientswithacutepulmonaryembolism
AT kritharidesleonard theprevalenceandincidenceofatrialfibrillationinpatientswithacutepulmonaryembolism
AT ngaustinchinchwan prevalenceandincidenceofatrialfibrillationinpatientswithacutepulmonaryembolism
AT adikaridona prevalenceandincidenceofatrialfibrillationinpatientswithacutepulmonaryembolism
AT yuandavid prevalenceandincidenceofatrialfibrillationinpatientswithacutepulmonaryembolism
AT laujerrettk prevalenceandincidenceofatrialfibrillationinpatientswithacutepulmonaryembolism
AT yongandyszechiang prevalenceandincidenceofatrialfibrillationinpatientswithacutepulmonaryembolism
AT chowvincent prevalenceandincidenceofatrialfibrillationinpatientswithacutepulmonaryembolism
AT kritharidesleonard prevalenceandincidenceofatrialfibrillationinpatientswithacutepulmonaryembolism